RxDoctor Payments Data

Peggy Watson, MD

Family Medicine · Montpelier, OHNPI 1376573964

Payments from drug & device makers

$1,898in general payments, 2019–2025

Across 125 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$390
  • Novo Nordisk$271
  • Pfizer$164
  • AstraZeneca$162
  • Exact Sciences$159
  • Boehringer Ingelheim$158
  • plus $595 from 13 others

What the payments were for

  • Food & beverage$1,898100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,898 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$57,692
Medicare patients
242
Services billed
966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban95$70,188
JardianceEmpagliflozin75$66,477
FarxigaDapagliflozin Propanediol42$47,726
MounjaroTirzepatide28$42,626
OzempicSemaglutide42$40,435
Breztri AerosphereBudesonide/Glycopyr/Formoterol44$32,049
TrulicityDulaglutide24$30,369
MyrbetriqMirabegron25$25,941
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$23,218
JanuviaSitagliptin Phosphate20$19,876
XareltoRivaroxaban26$16,220
Repatha SureclickEvolocumab17$10,485
Qvar RedihalerBeclomethasone Dipropionate13$3,596
Pregabalin44$2,638
Albuterol Sulfate HfaAlbuterol Sulfate95$2,423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$162$79,77586 claims
Lilly USA, LLCMounjaro, Trulicity$52$72,99552 claims
PfizerEliquis$164$70,18895 claims
Boehringer IngelheimJardiance$158$66,47775 claims
Novo NordiskOzempic$271$40,43542 claims
GSKTrelegy Ellipta$76$23,21836 claims
MerckJanuvia$72$19,87620 claims
Johnson & JohnsonXarelto$68$16,22026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Montpelier

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →